Labiana Health, S.A. (BME:LAB)

Spain flag Spain · Delayed Price · Currency is EUR
6.70
+0.10 (1.52%)
Last updated: May 18, 2026, 12:18 PM CET
Market Cap54.54M +139.1%
Revenue (ttm)71.67M +8.4%
Net Income904.36K
EPS0.13
Shares Out8.26M
PE Ratio51.05
Forward PE14.74
Dividendn/a
Ex-Dividend Daten/a
Volume4,588
Average Volume33,666
Open6.60
Previous Close6.60
Day's Range6.50 - 7.00
52-Week Range3.14 - 8.20
Beta0.17
RSI54.00
Earnings DateApr 21, 2026

About Labiana Health

Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms, bacterial vaccines and biological formats; and Fosfomycin trometamol under the Fosfomicina Labiana brand name. In addition, the company offers contrac... [Read more]

Sector Healthcare
Founded 1958
Employees 394
Stock Exchange Madrid Stock Exchange
Ticker Symbol LAB
Full Company Profile

Financial Performance

Financial Statements